Evaluation of peripheral blood neutrophil function in tumor-bearing dogs
BACKGROUND: Peripheral blood neutrophils of untreated human cancer patients have been shown to have normal, increased, and decreased phagocytic activity, killing capacity, and/or oxidative burst activities
Publié dans: | Veterinary clinical pathology. - 1975. - 39(2010), 2 vom: 01. Juni, Seite 157-63 |
---|---|
Auteur principal: | |
Autres auteurs: | , , , |
Format: | Article en ligne |
Langue: | English |
Publié: |
2010
|
Accès à la collection: | Veterinary clinical pathology |
Sujets: | Journal Article Tetradecanoylphorbol Acetate NI40JAQ945 |
Résumé: | BACKGROUND: Peripheral blood neutrophils of untreated human cancer patients have been shown to have normal, increased, and decreased phagocytic activity, killing capacity, and/or oxidative burst activities OBJECTIVES: The objectives of this study were to evaluate oxidative burst and phagocytic activities of peripheral blood neutrophils from tumor-bearing dogs before therapy and compare them with neutrophil function of healthy control dogs METHODS: Heparinized whole blood was obtained from dogs with high-grade lymphoma (n=23), sarcoma (n=13), or carcinoma (n=11), and healthy control dogs (n=11) for flow cytometric evaluation of oxidative burst and phagocytic activities. Percentage of bursting cells and amount of oxidative burst activity were determined after stimulation with phorbol 12-myristate 13-acetate (PMA) or Escherichia coli. Percentage of phagocytic cells and amount of phagocytic activity were determined after incubation with fluorescent E. coli RESULTS: Compared with control dogs, dogs with sarcoma (P=.004) and carcinoma (P=.05) had a lower percentage of neutrophils exhibiting oxidative burst activity after stimulation with PMA. Phagocytic activity was significantly lower in dogs with sarcomas compared with control dogs (P<.0001) and dogs with lymphoma (P=.01) CONCLUSIONS: Untreated carcinomas and sarcomas in dogs may suppress the percentage of neutrophils capable of oxidative burst when stimulated by PMA. Furthermore, sarcomas also may suppress the amount of phagocytic activity per neutrophil. Until further studies can be performed, the clinical significance of these findings is unknown |
---|---|
Description: | Date Completed 25.10.2010 Date Revised 20.10.2016 published: Print-Electronic Citation Status MEDLINE |
ISSN: | 1939-165X |
DOI: | 10.1111/j.1939-165X.2009.00200.x |